References:
- Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel
coronavirus in the United States. N Engl J Med. 2020; 382(10),
929–936
- World Health Organization. WHO characterizes COVID-19 as a pandemic.
Available at:
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
Accessed February 1, 2021
- Youssef M, Hussein M, Attia AS, et al. COVID‐19 and liver dysfunction:
A systematic review and meta‐analysis of retrospective studies. J Med
Virol. 2020; 92: 1825– 1833
- Suresh Kumar VC, Harne PS, Mukherjee S, et al. Transaminitis is an
indicator of mortality in patients with COVID-19: A retrospective
cohort study. World J Hepatol. 2020:12(9), 619–627
- Zhang JJ, Lee KS, Ang LW, Leo YS, Young BE. Risk factors for severe
disease and efficacy of treatment in patients infected with COVID-19:
a systematic review, meta-analysis, and meta-regression analysis. Clin
Infect Dis. 2020;71(16):2199-206
- Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in
COVID-19 patients: A retrospective analysis of 115 cases from a single
centre in Wuhan city, China. Liver Int. 2020;40(9):2095-2103
- Henry BM, Aggarwal G, Wong J, et al. Lactate dehydrogenase levels
predict coronavirus disease 2019 (COVID-19) severity and mortality: A
pooled analysis. Am J Emerg Med. 2020;38(9):1722-1726
- Mendoza M, Garcia-Ruiz I, Maiz N, et al. Pre-eclampsia-like syndrome
induced by severe COVID-19: a prospective observational study. BJOG.
2020;127(11):1374-1380
- Chen L., Li Q., Zheng D., Jiang H., Wei Y., Zou L. Clinical
characteristics of pregnant women with Covid-19 in Wuhan, China. N
Engl J Med. 2020;382:e100
- Deng G, Zeng F, Zhang L, Chen H, Chen X, Yin M. Characteristics of
pregnant COVID-19 patients with liver injury. J Hepatol. 2020;73(4),
989-991
- Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus
disease 2019 (COVID-19) in China: A systematic review and
meta-analysis. J Infect. 2020; 382:1708-1720
- Feng G, Zheng KI, Yan QQ, et al. COVID-19 and Liver Dysfunction:
Current Insights and Emergent Therapeutic Strategies. J Clin Transl
Hepatol. 2020;8(1):18‐24
- Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in
cholangiocytes may cause liver damage after 2019‐nCoV infection.
BioRxiv. 2020 Feb 4. Online ahead of print
- Adams DH, Hubscher SG. Systemic viral infections and collateral damage
in the liver. Am J Pathol. 2006;168(4), 1057–1059
- Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138
Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia
in Wuhan, China. JAMA. 2020;323(11), 1061–1069
- Fan Z, Chen L, Li J, et al. Clinical Features of COVID-19-Related
Liver Functional Abnormality. Clin Gastroenterol Hepatol. 2020;18(7),
1561–1566